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Deletion of the Mouse Glycine Transporter 2
Results in a Hyperekplexia Phenotype
and Postnatal Lethality
and neuronal neurotransmitter transporters, we have
employed homologous recombination in mouse to inac-
tivate the transporters known to catalyze the re-uptake
of glycine. In the accompanying paper, we reported on
the phenotype of mice deficient in the glial glycine trans-
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Max-Planck-Institute for Brain Research porter 1 (GlyT1). GlyT1/ mice die on the first postnatal
Deutschordenstrasse 46 day, due to severe motor and respiratory deficits re-
60528 Frankfurt sulting from overinhibition (Gomeza et al., 2003 [this issue
Germany of Neuron]). Here, we describe a mouse line that lacks
2 Department of Neuro- and Sensory Physiology functional glycine transporter 2 (GlyT2), the neuronal
University of Go¨ttingen GlyT isoform localized in presynaptic terminals of gly-
Humboldtallee 23 cinergic interneurons (Zafra, 1995a; Spike et al., 1997).
37073 Go¨ttingen We report that GlyT2-deficient mice display a severe
Germany neuromotor disorder characterized by muscular spas-
ticity. The animals die during the second week after birth,
revealing a previously unrecognized vital role for GlyT2
Summary in postnatal life. The phenotype of these mice is consis-
tent with GlyT2 being essential for replenishing the cyto-
The glycine transporter subtype 2 (GlyT2) is localized plasmic pool of glycine that is needed for transmitter
in the axon terminals of glycinergic neurons. Mice defi- loading of synaptic vesicles in glycinergic nerve termi-
cient in GlyT2 are normal at birth but during the second nals. Moreover, it mimics symptoms seen in human he-
postnatal week develop a lethal neuromotor deficiency reditary hyperekplexia (or startle disease) and therefore
that resembles severe forms of human hyperekplexia identifies the GlyT2 gene as a candidate disease gene
(hereditary startle disease) and is characterized by spas- in human patients. Together, our two studies define dis-
ticity, tremor, and an inability to right. Histological and tinct roles of GlyT1 and GlyT2 in glycine-mediated syn-
immunological analyses failed to reveal anatomical aptic transmission.
or biochemical abnormalities, but the amplitudes of
glycinergic miniature inhibitory currents (mIPSCs) were
strikingly reduced in hypoglossal motoneurons and Results
dissociated spinal neurons from GlyT2-deficient mice.
Thus, postnatal GlyT2 function is crucial for efficient Generation of GlyT2/ Mice
transmitter loading of synaptic vesicles in glycinergic The GlyT2 gene was inactivated in mouse E14 (129/OLA)
nerve terminals, and the GlyT2 gene constitutes a candi- embryonic stem cells by replacing a segment of 2.1 kb,
date disease gene in human hyperekplexia patients. which contains the exon encoding the fourth transmem-
brane domain of the transporter, with a neomycin-resis-
Introduction tance cassette (Figure 1A). By using standard transgenic
and mouse breeding techniques, chimeric mice were
Amino acids serve as neurotransmitters throughout the obtained and used to generate F1 offspring heterozy-
animal kingdom. Glutamate is the predominant excit- gous for GlyT2. These animals appeared phenotypically
atory transmitter, and -aminobutyric acid (GABA) and normal and showed undisturbed development and fertil-
glycine are the major inhibitory transmitters in the mam- ity. Intercrossing of the heterozygous mice generated
malian CNS. The postsynaptic actions of these amino wild-type (/) as well as heterozygous (/) and ho-
acids are terminated by specific ion-driven transporter mozygous (/) GlyT2 mutant mice, as determined by
proteins, which mediate transmitter re-uptake into nerve Southern blot analysis (Figure 1B).
terminals as well as glial cells (for review, see Amara and GlyT2/ newborn pups were obtained with the ex-
Kuhar, 1993; Schloss et al., 1994; Nelson, 1998). Notably, pected Mendelian frequency, indicating that there was
all amino acid transporters exist in different subtypes no increased embryonic mortality in the mutant mice.
encoded by different genes, which often show a restricted RT-PCR experiments showed that GlyT2 mRNA was
expression in either glia or neurons. This suggests that present in caudal regions of the CNS in wild-type mice,
the functional roles of glial and neuronal transporters whereas no PCR product was obtained with mRNA ex-
are distinct. tracted from GlyT2/ brain stem (Figure 1C). Thus, GlyT2
In an attempt to elucidate the in vivo functions of glial transcripts were absent in the homozygous mutants.
Similarly, Western blot analysis with an antiserum raised
*Correspondence: neurochemie@mpih-frankfurt.mpg.de in rabbits against the N-terminal cytoplasmic domain of
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Institute, University of Copenhagen, DK-2200 Copenhagen, Denmark.
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Figure 1. Targeted Disruption of the Mouse
GlyT2 Gene
(A) Knockout strategy showing restriction
maps of the wild-type GlyT2 locus, the tar-
geting construct, and the targeted allele. Ex-
ons are represented as black boxes. The
probe used for Southern analysis and the
sizes of the restriction fragments detected
with this probe are indicated. Only relevant
restriction sites are shown. St, StuI; Ns, NsiI;
Bg, BglII; H, HindIII; Nh, NheI; Sa, SacI; Ba,
BamHI; E, EcoRI.
(B) Genotyping of F2 offspring by Southern
blot analysis of NsiI/EcoRI-digested mouse
tail DNA. The 5.5 kb and 4.0 kb bands repre-
sent the wild-type and mutant GlyT2 alleles,
respectively.
(C) RT-PCR analysis of brain stem expression
of GlyT2, -actin, and GlyT1 in wild-type and
GlyT2/ and GlyT2/ mice. Note the ab-
sence of GlyT2 transcripts in homozygous
mutant animals.
(D) Western blot analysis of brain stem and
spinal cord fractions (30 g protein/lane) us-
ing the GlyT2 antibody. Note that the GlyT2
polypeptide is absent in the homozygous mu-
tant mice.
GlyT2/ Mice Display Low Glycine Transport zygous mutant cerebellum, a region known to contain
few glycinergic interneurons. In contrast, all genotypesActivity in Caudal Regions of the CNS
In order to reveal the functional consequences of GlyT2 analyzed showed comparable [3H]glycine uptake values
with membrane fractions prepared from frontal cortex,gene deletion, [3H]glycine uptake assays were performed
with P2 membrane fractions prepared from different re- where GlyT2 is not expressed and glial GlyT1 constitutes
the only GlyT isoform that catalyzes the clearance ofgions of the mouse CNS at the tenth postnatal day (P10).
As shown in Figure 2, [3H]glycine transport was reduced extracellular glycine (Zafra et al., 1995a, 1995b). These
results are consistent with a complete lack of GlyT2-by about 65% and 73% in brain stem and spinal cord
membrane preparations from GlyT2/ mice, respec- mediated glycine uptake in the homozygous mutant mice.
tively, as compared to membrane samples obtained
from wild-type animals (p 0.001). This result is consis-
GlyT2/ Mice Show a Strong Neuromotor Phenotypetent with the known expression profiles of GlyT1 and
and Die during the Second Postnatal WeekGlyT2 during postnatal development (Zafra et al., 1995b;
Body weight and general appearance of the homozy-Friauf et al., 1999). Also, a more modest (25%) but signifi-
gous GlyT2/ pups were normal at birth. However, GlyT2cant reduction was found with membranes from homo-
mutant animals gained weight more slowly than their
wild-type littermates (Table 1). Unexpectedly, homozy-
gous GlyT2/ mice died prematurely around the end of
the second postnatal week after displaying a complex
neuromotor phenotype characterized by spasticity, a
rigid muscle tone, strong tremor, and a severely impaired
righting response. In most homozygous animals, these
symptoms were clearly seen at P10; usually, first signs
of an increased muscle tone were already detectable at
P8. Only an extremely low number of pups already dis-
played spasticity and tremor at P9, or after P10, i.e., at
P11 only. Homozygous animals therefore were routinely
killed at P10 for analysis.
In an attempt to monitor the phenotypic properties of
these mutant mice more closely, simple handling assays
Figure 2. High-Affinity Glycine Uptake in Different CNS Regions of were performed at P10. First, littermates were screened
Wild-Type, Heterozygous, and Homozygous GlyT2-Deficient Mice for the development of tremors. Tremor could be easily
Membranes were prepared from the indicated tissues of 10-day- induced and properly recorded when animals were
old mice and preincubated for 1 min at 37C. Transport was initiated picked up and fixed by their tails onto an electromechan-
by the addition of 2 M [3H]glycine in Krebs-Henseleit buffer for 1 ical transducer, as described previously (Becker et al.,
min. Cx, cortex; Cer, cerebellum; BS, brainstem; SC, spinal cord.
2000). Vibrations produced by tremor-derived movementsData are given as means SD (n	 3–4 for each genotype). Asterisk
were recorded over time as apparent weight changes.indicates significantly different from wild-type mice, p  0.001 (Stu-
dent’s t test). In contrast to wild-type and heterozygous littermates,
Glycine Transporter 2 Knockout Mice
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Table 1. Phenotype Characteristics of Littermates
Genotype (n) / (20) / (18) / (13)
Body weight (g) 7.91  1.09 8.05  1.13 4.53  0.99a
Hind feet clasping (%) 0 0 100
Tremor (%) 0 0 100
Righting time 
1 s (%) 100 100 0
Data are expressed as means  SD.
a Significantly different from the wild-type value, p  0.001 (Student’s t test).
all GlyT2/mice developed strong spontaneous tremor, on their back, and the time required to regain the upright
position was determined. Wild-type and heterozygousas demonstrated by high amplitudes of the electrome-
chanical tracings, which reflect strong tremor-induced animals immediately turned themselves over, righting
themselves onto all four legs. Notably, GlyT2/ micemovements (Figure 3A). As a second criterion to evalu-
ate neuromotor performance, we scored the so-called were unable to perform this task and never righted them-
selves, as indicated in Table 1. In summary, GlyT2-defi-“hind feet clasping” behavior that characterizes mice
carrying mutations in GlyR structural genes (Hartenstein cient mice displayed a lethal neuromotor disorder that
developed after the first postnatal week and was charac-et al., 1996; Becker et al., 2000). When picked up by
their tail, GlyT2/ and GlyT2/ mice tended to move terized by muscular spasticity, tremor, and an inability
to right. Death presumably occurred as a consequenceheavily while spreading out their legs. In contrast, GlyT2
mutant animals showed an abnormal behavior, clasping of the inability to feed, desiccation, and continued con-
vulsions.their hind feet between episodes of tremor, as shown
in Figure 3B. Finally, a third parameter measured to
monitor animal motor performance was the righting re- GlyT2/ Mice Show Normal Histology
sponse reflex (Hartenstein et al., 1996). Mice were turned and Synaptic Protein Expression
To exclude the possibility that the lethal phenotype of
GlyT2/ mice is due to developmental abnormalities, a
general histological analysis was performed. No defects
in skeletal muscles or visceral organs were found in 10-
day-old mutant animals (data not shown). Similarly, no
differences between GlyT2/ and GlyT2/ mice were
detected when examining brain stem and spinal cord
sections (Figure 4A). Thus, homozygous GlyT2/ animals
appeared histologically indistinguishable from GlyT2/
littermates.
Depression of glycine uptake, due to inactivation of
GlyT2, might cause compensatory changes in the ex-
pression of synaptic proteins. Western blot analysis per-
formed on spinal cord membranes prepared from P10
wild-type and GlyT2-deficient mice as described (Go-
meza et al., 2003) showed that the immunoreactivities
of the postsynaptic GlyR clustering protein gephyrin
(Pfeiffer et al., 1984; Prior et al., 1992), the NMDA recep-
tor subunit NR1 (Moriyoshi et al., 1991), the NMDA re-
ceptor anchoring protein PSD-95 (Cho et al., 1992), the
vesicular inhibitory amino acid transporter (VIAAT) (Du-
moulin et al., 1999), the presynaptic membrane protein
syntaxin (Bennett et al., 1992), GlyR  subunits (GlyR;
Pfeiffer et al., 1984), and GlyT1 (Zafra et al., 1995a) all
were rather similar in all genotypes studied (Figure 4B).
Quantitation of the immunreactive bands in 3–4 inde-
pendent membrane samples each corroborated that
average protein levels were unchanged upon GlyT2 defi-Figure 3. Neuromotor Behavior of P10 GlyT2/ Mice
ciency (Table 2). Similarly, immunocytochemical stain-(A) Electromechanical tracings of tremor-derived movement re-
ings of brain stem and spinal cord sections from 10-day-corded from three wild-type (/) and three GlyT2 mutant (/)
animals. All traces represent 1 s recordings. The amplitudes are old littermates revealed a lack of GlyT2 immunoreactivity
proportional to the strength of the movement recorded over time. in brain stem from homozygous mutant animals (Figure
Note the appearance of spontaneous strong tremor in GlyT2/ 4C), but a VIAAT-specific antibody produced compara-
mice. ble patterns of immunoreactivity on parallel GlyT2/
(B) “Hind feet clasping” phenotype in GlyT2/ mice. When picked
and wild-type sections (Figure 4C). Thus, a loss of inhibi-up by their tail, wild-type mice (/) tend to move heavily, spreading
tory presynaptic terminals can be excluded. Also, noout their legs (left). GlyT2 homozygous animals (/) in this situation
clasp their hind feet (right) between episodes of tremor. differences in the postsynaptic punctate staining of GlyR
Neuron
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Figure 4. Histological and Immunochemical
Analyses of Wild-Type (/) and GlyT2/
Mice
(A) Cresyl violet-stained spinal cord sections
from P10 wild-type (/) and GlyT2 mutant
(/) mice are shown. No defects were de-
tected in the homozygous mutants, and the
overall anatomy appeared normal in all ani-
mals analyzed.
(B) Western blot analysis of spinal cord frac-
tions prepared from P10 wild-type (/), het-
erozygous (/), and homozygous (/)
GlyT2 mutant animals. Equal amounts of pro-
tein (30g/lane) were loaded and probed with
the indicated antisera. Note that the expres-
sion levels of all proteins tested were similar
in the different genotypes.
(C) Immunostaining of brainstem sections
with antibodies specific for GlyT2 and VIAAT.
No differences in staining were detected
when comparing sections from P10 GlyT2
mutant (/) and wild-type (/) animals ex-
cept for GlyT2 immunoreactivity, which was
absent in the mutant sections. LSO, lateral
superior olivary complex.
(D) Immunostainings of P10 spinal cord sec-
tions with antibodies specific for GlyR and
gephyrin. Note similar punctate staining pat-
terns in the different sections.
(E) Postnatal changes in GlyR (mAb 4b) and
GlyR1 (mAb 2a) immunoreactivities in spinal
cord sections prepared from wild-type and
GlyT2/ animals. At birth, 1 was expressed
at a comparatively low level but increased
about 3-fold until P10 in both genotypes,
whereas GlyR values changed only mod-
estly.
(F) At both birth (P0) and P10, the punctate
synaptic distributions of GlyR1 staining
were comparable in GlyT2/ and wild-type
sections. Scale bar equals 20 m.
 subunits were detected when comparing GlyT2 mutant expression during postnatal development. Spinal cord
sections were stained using the antibody mAb 2a thatand wild-type spinal cord preparations (Figure 4D). Like-
wise, the density of gephyrin immunoreactive puncta specifically detects the1 subunit of the GlyR (Pfeiffer et
al., 1984; Schroder et al., 1991). Consistent with previouswas unaltered in spinal cord sections of GlyT2/ mice.
Taken together, these results indicate that no compen- reports (Becker et al., 1988, 1992), in wild-type sections
the intensity of GlyR1 immunoreactivity visualized bysatory changes occur in the expression and synaptic
localization of glycine transmission-related synaptic mAb 2a was low at birth but increased about 3-fold until
P10, although total GlyR amounts as quantified by mAbproteins upon GlyT2 gene inactivation.
Since the onset of neurological symptoms in GlyT2/ 4b staining changed only little (Figure 4E). This postnatal
increase in GlyR1 expression was unaltered in spinalmice coincides with the postnatal replacement of the
neonatal GlyR 2 by the adult GlyR 1 subunit (Becker cord sections of GlyT2 mutant animals. Moreover, the
punctate distribution of mAb 2a staining indicative ofet al., 1988; Malosio et al., 1991), we examined GlyR1
postsynaptically clustered GlyRs also was indistinguish-
able in GlyT2/ and GlyT2/ sections at both at P0
Table 2. Quantification of Synaptic Protein Immunoreactivities and P10 (Figure 4F). We therefore conclude that the
absence of GlyT2 does not affect postnatal GlyR  sub-Genotype GlyT2/ GlyT2/ GlyT2/
unit expression and localization in developing spinal
GlyR 100  14 96  11 111  12
neurons.Gephyrin 100  18 86  14 110  7
NR1 100  7 109  9 93  7
PSD95 100  12 77  19 107  13 Reduction of Glycinergic IPSCs in GlyT2/
VIAAT 100  7 123  21 109  15 Hypoglossal Motoneurons
Syntaxin 100  20 75  16 91  11 To examine the effects of GlyT2 gene deletion on gly-
GlyT1 100  14 96  9 90  9
cinergic neurotransmission, spontaneous glycinergic
Values were determined by scanning immunoreactive bands on postsynaptic currents (IPSCs) were recorded in hypo-
Western blots and represent means  SD (n  3). None of the glossal motoneurons in acutely isolated brainstem slices
mutant values differs significantly from wild-type levels.
from 8- to 9-day-old wild-type and GlyT2/ mice. At this
Glycine Transporter 2 Knockout Mice
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15.9  3.9 pA (n 	 6, p  0.001). The mean mIPSC
frequency in wild-type neurons was 2.5  1.1 Hz (n 	
4). In GlyT2/ mice, the frequency of mIPSCs was re-
duced to 0.4  0.4 Hz (n 	 6, p 	 0.001). The decay of
mIPSC was not significantly changed in the mutant (wild-
type, 14.4  2.7 ms versus GlyT2/, 11.9  5.9 ms).
Reduced Glycinergic mIPSCs in Cultured
GlyT2/ Spinal Neurons
As viable brain stem slices were difficult to prepare at
stages later than P9, glycinergic mIPSCs were in addi-
tion recorded from dissociated cell cultures prepared from
wild-type and GlyT2/ E13 embryonic mouse spinal
cord after 21 days of in vitro differentiation, i.e., a time
period corresponding to the end of the second postnatal
week (Figure 6A). Cultured neurons from wild-type ani-
mals displayed a regular burst pattern, with a frequency
of 26.4  6.6 Hz (mean  SD; n 	 5; Figure 6B). No
significant change in inter-mIPSC intervals was ob-
served in preparations from GlyT2/ mutant mice,
which displayed a burst frequency of 23.2  5.6 Hz (n 	
5). Notably, however, mIPSC amplitudes were signifi-
cantly reduced in the GlyT2/ neurons (Figure 6A).
Compared to wild-type cells, a mean decrease of 42%
15% (p  0.01) in the peak amplitude of the average
mIPSC was observed in GlyT2/ spinal cord neurons
(Figure 6B). Application of the GlyR antagonist strych-
nine abolished mIPSC events in both wild-type and mu-
tant cultures, thereby confirming the glycinergic nature
of the recorded mIPSC (Figure 6A). No differences were
found in the kinetics of mIPSC decay between wild-type
and GlyT2/ neurons. Averaged mIPSCs (50 consecu-
tive events) decayed with a time constant of 9–12 msFigure 5. Amplitudes and Frequencies of Spontaneous IPSCs Re-
corded from Hypoglossal Motoneurons In Situ at Postnatal Days 8 in cultures form wild-type mice and 9–14 ms in those
and 9 from GlyT2/ mice (n 	 3, each).
(A and B) Chart recordings of typical spontaneous synaptic activity To exclude a possible postsynaptic origin of the re-
in hypoglossal motoneurons in slices from wild-type (/, A) and duced mIPSC amplitudes found in the mutant cultures,
GlyT2-deficient (/, B) mice. The mean IPSC amplitudes shown the synaptic localization of GlyR was examined in thein these representative traces were 45.0  36.7 pA (control) and
cultured neurons (Figure 6C). In wild-type cells, a punc-16.7  3.1 pA (GlyT2/).
tate staining was produced by mAb 4b that was predom-(C and D) Summary graphs showing the IPSC mean amplitudes (C)
and frequencies (D) found in wild-type (/; n 	 6) and GlyT2/ inantly membranous, as revealed by confocal sectioning.
(/; n 	 11) hypoglossal motoneurons. Confirming the results obtained from spinal cord sec-
tions, mAb 4b staining of GlyT2/ neurons did not differ
from that of wild-type cells. Again, a clear punctate dis-
tribution of GlyR immunoreactivity was found. Also,stage, the first neuromotor deficits become apparent.
the GlyR 1 subunit-specific antibody mAb 2a producedHypoglossal motoneurons from wild-type animals gen-
a very similar punctate pattern in cultures prepared fromerated glycinergic IPSCs with a mean amplitude of
both genotypes (data not shown). As no alterations in46.5  16.5 pA (n 	 6; Figures 5A and 5C). In GlyT2/
synaptic GlyR staining could be detected under both inneurons, mean IPSC amplitudes were significantly re-
vivo and in vitro conditions, we conclude that the GlyT2duced (17.4  4.4 pA; n 	 11, p  0.001; Figures 5B
deficiency exerts exclusively presynaptic effects. Ourand 5C). Mean IPSC frequencies in wild-type neurons
data indicate that the absence of GlyT2 reduces thewere 14.9  10.5 Hz (n 	 6) and in GlyT2/ cells 2.1 
amplitude but not the frequency of glycinergic mIPSCs,3.2 Hz (n 	 11, p 	 0.001) (Figure 5D). We attribute this
a finding that accounts for the reduced glycinergic activ-reduction in IPSC frequency to small events that were
ity of the mutant animals.not detectable in the comparatively high noise of these
recordings (Figure 5B).
We also analyzed action potential-independent IPSCs Discussion
(mIPSCs) in the presence of 0.5M tetrodotoxin and 100
mM sucrose (data not shown). Under these conditions, GlyT2 Is Essential for Vital Postnatal Functions
Here, we report a genetic analysis of the in vivo functionmIPSCs in hypoglossal motoneurons from wild-type ani-
mals showed an amplitude of 28.8  7.9 pA (n 	 4), of the neuronal GlyT subtype, GlyT2, in the mouse cen-
tral nervous system. As demonstrated by Southern blot-whereas the mIPSC amplitudes in GlyT2/ neurons
were significantly reduced, with a mean amplitude of ting, RT-PCR, Western blot analysis, and glycine uptake
Neuron
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Figure 6. Amplitudes and Frequencies of
mIPSCs Recorded from Cultured Spinal Neu-
rons after 21 Days In Vitro
(A) Chart recordings of typical spontaneous
synaptic activity in spinal cord cells isolated
from wild-type (/) and GlyT2-deficient
(/) embryos in the presence of tetrodo-
toxin (0.5 M). The mean mIPSC amplitudes
shown in these representative traces were
54.4  15.4 pA (wt) and 28.8  10.1 pA
(GlyT2/). The lower traces (Stry) were re-
corded in the presence of 200 nM strychnine.
(B) Summary graph showing the relative
changes in mIPSC mean amplitudes and fre-
quencies found in GlyT2/ neurons. Values
are normalized to control values obtained
with wild-type cells (n 	 5, each).
(C) Immunohistochemical localization of GlyR
clusters on cultured mouse spinal neurons
stained with mAb 4b. The anti-GlyR antibody
was visualized with FITC-labeled secondary
antibody (green). Scale bar equals 20 m.
assays, inactivation of the GlyT2 gene by homologous walter et al., 1994; Ryan et al., 1994; Saul et al., 1994;
Kling et al., 1997). In contrast, the mutant spa has anrecombination caused a complete loss of transporter
expression in caudal regions of the CNS. Our results intronic insertion of a transposable LINE-1 element in
the GlyR  subunit gene that leads to a strong reductionconfirm the authenticity of the GlyT2/ line and exclude
the possibility that loss of GlyT2 may lead to compensa- in the levels of mature  subunit mRNA and, conse-
quently, low levels of GlyR at the synaptic plasma mem-tory upregulation of the functionally closely related glial
transporter, GlyT1. The severe phenotype observed in brane (Kingsmore et al., 1994; Mulhardt et al., 1994;
Hartenstein et al., 1996). Similarly, loss of the GlyR an-the homozygous knockout mice thus can be confidently
attributed to GlyT2 deletion. choring protein gephyrin in gephyrin knockout mice pre-
vents synaptic accumulation of GlyRs and leads to aGlyT2/ mice appeared normal at birth but died dur-
ing the second postnatal week after developing a severe lethal phenotype that mimics symptoms seen upon
strychnine poisoning (Feng et al., 1998). In conclusion,neuromotor disorder, whose symptoms were entirely
different from those seen upon GlyT1 deletion (Gomeza impaired postsynaptic GlyR function or clustering causes
a phenotype that closely resembles that of GlyT2/ an-et al., 2003). As in GlyT1/ mice, no histological defects
were detected in peripheral organs or in caudal regions imals.
Because of these similarities, we considered the pos-of the CNS, where GlyT2 is mainly expressed. We there-
fore conclude that GlyT2, like GlyT1, is not required for sibility that the neurological symptoms of GlyT2/ mice
might be due to changes in GlyR expression or postsyn-organogenesis during embryonic development but is
essential for postnatal CNS functions. aptic clustering. Up- or downregulation of distinct com-
ponents of synapses has been observed previously in
monoamine transporter knockout mice (Bengel et al.,GlyT2 Deficiency Results in a Complex
Neuromotor Disorder 1998; Gainetdinov et al., 1998; Jones et al., 1998, 1999).
However, ablation of the GlyT2 gene did not lead toThe neuromotor phenotype of GlyT2 mutant animals
develops during the second postnatal week and is char- detectable changes in the expression levels of GlyR
subunits, as revealed by Western blot analysis. Likewise,acterized by rigidity, tremor, and an impaired righting
response. Interestingly, alterations in glycinergic neuro- our immunofluorescence studies showed that the distri-
bution and density of GlyR subunit puncta were unal-transmission are known to underlie the pathogenesis
of neurological dysfunctions displaying rather similar tered in spinal cord sections derived from GlyT2-defi-
cient mice. Previous studies on brain stem neurons havesymptoms (Kuhse et al., 1995; Rajendra and Schofield,
1995; Breitinger and Becker, 1998). Spastic (spa), spas- revealed an excellent correlation of punctate GlyR and/
or gephyrin immunoreactivities (Triller et al., 1985) withmodic (spd), and oscillator (spdot) mutant mice are nor-
mal at birth but develop an exaggerated startle reflex, the size of the postsynaptic response as defined by
mIPSC amplitude measurements (Lim et al., 1999).inducible rapid tremor, rigidity, and impaired righting
reflexes at the end of the second postnatal week. The Hence, our results imply that the density of postsynaptic
GlyRs is unchanged. Similar findings were obtainedmutations spd and spdot represent partial or complete
loss-of-function mutations of the GlyR1 subunit (Buck- when the expression levels and localization of other
Glycine Transporter 2 Knockout Mice
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Figure 7. Model of GlyT1 and GlyT2 Func-
tions at Glycinergic Synapses
The different localizations of the two GlyTs
are depicted. The neuronal GlyT isoform
GlyT2 is essential for glycine uptake into the
nerve-terminal cytosol and thereby provides
substrate for VIAAT-mediated refilling of re-
endocytosed synaptic vesicles, whereas the
glial isoform GlyT1 removes released glycine
from postsynaptic GlyRs and allows for its
degradation by the glial glycine cleavage sys-
tem (GCS). Consequently, the two transport-
ers cooperate functionally at different steps
of glycine neurotransmitter life cycle. For de-
tails, see text.
pre- and postsynaptic components were analyzed. Fur- ized in some distance from the glycine-releasing active
zones confined to the synaptic cleft region (Zafra et al.,thermore, GlyR cluster immunfluorescence in cultured
spinal neurons prepared from the knockout mice was 1995a; Poyatos et al., 1997; Spike et al., 1997; Mahen-
drasingam et al., 2000). This location suggests that theindistinguishable from that seen in wild-type cells. To-
gether with our results on GlyT1/ mice (Gomeza et al., primary role of GlyT2 might not be clearance of glycine
from the synaptic cleft but replenishment of neuro-2003), these data indicate that GlyT proteins are not
required for the formation of pre- and postsynaptic transmitter into presynaptic boutons. Here, recording of
spontaneous IPSCs and/or mIPSCs from hypoglossalmembrane specializations. Furthermore, ablation of the
corresponding genes does not cause adaptive alter- motorneurons in situ and from spinal cord cultures dem-
onstrated that the amplitudes of GlyR-mediated mIPSCsations in synapse biochemistry.
are reduced upon GlyT2 deficiency. As discussed above,
synaptic GlyR immunoreactivities in both sections andGlyR Isotype Switching Proceeds Normally
in GlyT2-Deficient Mice cultured neurons from spinal cord were indistinguish-
able between wild-type and GlyT2/ samples. Thus,Expression of the different GlyR subunits is develop-
mentally regulated throughout the mammalian CNS (re- changes in receptor number cannot account for the re-
duced mIPSC amplitude. At GABAergic synapses, inhi-viewed in Kuhse et al., 1995; Laube et al., 2002). GlyR2
is the fetal subunit isoform predominant at birth (Becker bition of GABA transport has been shown to result in a
reduction in IPSC and, to some extent, mIPSC ampli-et al., 1988; Malosio et al., 1991), whereas 1 is the
major adult subunit that replaces 2 during the first two tudes (Overstreet et al., 2000). This has been attributed
to postsynaptic receptor desensitization by elevatedweeks of postnatal life (Grenningloh et al., 1990; Becker
et al., 1992; Singer et al., 1998). Consequently, the dura- levels of extracellular GABA. However, desensitization
of postsynaptic GlyRs is unlikely to cause the changestion of postsynaptic glycine currents is gradually re-
duced postsynaptically because of a progressive transi- seen in GlyT2/ neurons, since (1) in our spinal cord
cultures, released glycine should be rapidly diluted intotion from the kinetically slow 2 to the fast 1 GlyR
(Takahashi et al., 1992; Singer et al., 1998). At intermedi- the culture medium, and (2) GlyRs desensitize poorly
even in the presence of high agonist concentrations.ate developmental stages, glycinergic synapses ex-
press variable proportions of 2 and 1 subunits, which Furthermore, in the accompanying manuscript we show
that the amplitude of glycinergic IPSC is not reducedresult in postsynaptic currents of intermediate duration
(Singer et al., 1998). Thus, alterations in the expression upon increasing extracellular glycine levels by GlyT1
deletion (Gomeza et al., 2003). Together, these observa-levels or localization of these GlyR subunits might ac-
count for the abnormal phenotype seen in GlyT2/ tions argue against a postsynaptic origin of the observed
reduction in mIPSC amplitudes and suggest that themice. Therefore, we examined the postnatal expression
of the GlyR1 subunit in spinal cord sections of GlyT2/ consequences of GlyT2 deficiency are exclusively pre-
synaptic. In slice preparations, a decrease in IPSC andmice and wild-type littermates. In the latter, low levels
of the 1 subunit were present at birth, which increased mIPSC frequencies was additionally seen, which was
not apparent in recordings from cultured cells. We attri-about 3-fold during the first 10 postnatal days. No differ-
ences were found during this developmental period in bute this difference to a loss of small events resulting
from the relatively high noise levels present in slices. Inthe fluorescence intensity and localization of 1-immu-
noreactive puncta between wild-type and GlyT2 knock- summary, our results support the view that GlyT2 func-
tion is required for the maintenance of normal quantalout sections, indicating that the postnatal switch of
GlyR subunit isoforms is not affected in GlyT2/ ani- glycine contents in synaptic vesicles. Apparently, gly-
cinergic neurotransmission critically depends on an ap-mals. Hence, the severe phenotype observed in GlyT2/
mice cannot be attributed to an alteration in GlyR sub- propriately sized pool of glycine in the presynaptic termi-
unit composition. nal, which cannot be maintained by intraneuronal glycine
synthesis alone. We therefore conclude that the primary
function of GlyT2 is to provide substrate for the VIAAT-Essential Function of GlyT2 in Glycinergic
Synaptic Neurotransmission catalyzed transport of glycine into synaptic vesicles
rather than to shape the time course of glycinergic neu-Immunocytochemical studies have shown that, similar
to other neurotransmitter transporters, GlyT2 is local- rotransmission. Our inability to detect differences in
Neuron
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St. Louis, MO) by hybridization with a PCR fragment correspondingmIPSC decay kinetics between wild-type and GlyT2/
to the region of the GlyT2 cDNA that encodes the fourth up to theneurons lends further support to this conclusion.
seventh transmembrane domain. The targeting vector consisted ofThe interpretation given above is also consistent with
a 9.5 kb genomic sequence, in which a 1.9 kb fragment encom-
the “spastic” phenotype of the GlyT2/ mice and con- passing the exon encoding the fourth transmembrane region was
trasts the overinhibition seen in mutant mice deficient replaced with the 1.8 kb PGK-neomycin resistance gene (PGK-neo).
in GlyT1, the glial transporter isoform that is responsible A 2.8 kb Herpes simplex virus thymidine kinase gene fragment was
attached to the 5 end of the construct for negative selection. Allfor the control of extracellular glycine levels (Gomeza
subsequent procedures were identical to those described in theet al., 2003). Taken together, the available knockout data
accompanying paper (Gomeza et al., 2003), except that a 5 externalsuggest that GlyT1 and GlyT2 have rather distinct func-
probe was used for Southern blot analysis. From a total of 198
tions at glycinergic synapses (Figure 7). The glial trans- clones screened, two had been targeted properly. These were used
porter GlyT1 is crucial for lowering glycine concentra- for generating chimeric mice with an inactivated GlyT2 allele.
tions in the synaptic cleft and thereby ensures efficient
silencing of GlyR activation (Gomeza et al., 2003). Within Behavioral Characterization of GlyT2/ Mice
The methods used for monitoring the neuromotor performance ofthe glial cytosol, glycine is then degraded by the glycine
GlyT2/ mice have been described (Hartenstein et al., 1996; Beckercleavage system (Sakata et al., 2001). In contrast, GlyT2-
et al., 2000). Briefly, hind feet clasping behavior was induced bydriven glycine uptake is essential for the refilling of syn-
lifting the animals by their tails. For tremor recordings, mice wereaptic vesicles by VIAAT. Thus, the two mammalian GlyTs
fixed by their tail to a F30 force transducer (Type 372) connected
control different steps in glycine turnover at inhibitory to a bridge amplifier (Type 336, both from Hugo Sachs Elektronik,
synapses. The late manifestation of the neuromotor phe- 79229 March-Hugstetten, Germany) and a conventional recorder.
notype observed with GlyT2/ animals may relate to the For righting response quantification, mice were brought into a su-
pine position by twitching the tail, and the time that elapsed afterpostnatal GlyR isotype switch that proceeds normally in
release of the tail until resuming an upright position was determined.the mutants. At “slow” neonatal 2 GlyRs characterized
by long mean channel open times (Takahashi et al.,
Preparation of Spinal Cord Cultures1992; Singer et al., 1998), even release events of reduced
Spinal cords were removed from 13-day-old mouse embryos thatquantal content may produce sufficient postsynaptic
had been killed by decapitation, dissected in phosphate-buffered
inhibition, whereas a higher number of receptors must saline (PBS) supplemented with 33 mM glucose, and dissociated
be activated at postsynapses containing predominantly by trituration as described (Kirsch and Betz, 1995). The cells were
“fast” adult 1 GlyRs, which exhibit short mean channel plated into a 24-well cluster onto poly-L-lysine-coated coverslips
and kept in primary culture for 3 weeks.open times.
Immunochemistry and Confocal MicroscopyGlyT2/ Mice, a New Model
Coverslips carrying spinal neurons were fixed in 95% (v/v) methanolfor Human Hyperekplexia?
and 5% (v/v) acetic acid and air-dried. Cells were then permeabilizedThe results presented in this study reveal a previously
in 0.2% (w/v) Triton X-100 for 5 min followed by incubation in 5%
unrecognized vital role for GlyT2 in postnatal life. More- (v/v) goat serum for 20 min prior to processing for immunofluores-
over, they provide strong evidence that the major func- cence as described (Kirsch and Betz, 1995; Laube, 2002). To obtain
tion of GlyT2 in the CNS is to transport extracellular spinal cord and brain stem sections, tissue was cut in blocks of 5
mm and immediately frozen. Cryostat sections were fixed for 2 minglycine into presynaptic boutons. In addition, GlyT2/
in 4% (w/v) paraformaldehyde and processed for immunofluores-mice display a severe neuromotor disorder character-
cence. Confocal microscopy was performed using a confocal laser-ized by spasticity, muscular rigidity, tremor, and im-
scanning microscope Leica TCS-SP (Wetzlar, Germany) equippedpaired righting response. These symptoms are similar
with the image software Leica-TCS-NT version 1.6.551.
to those associated with a group of human hereditary
motor diseases that develop in early postnatal life, Electrophysiological Recordings from Acutely
named startle disease or hyperekplexia (Rajendra and Isolated Hypoglossal Slices
Schofield, 1995; Andrew and Owen, 1997; Tijssen et 200–300m slices of the caudal medulla containing the hypoglossal
nucleus from P8–P9 mice were prepared as described (Hu¨lsmannal., 1997). Some dominant and recessive forms of this
et al., 2000).disease are known to be associated with missense mu-
Whole-cell recordings were obtained with an L/M-PCA patchtations in the 1 subunit gene of the inhibitory GlyR
clamp amplifier (E.S.F., Go¨ttingen, Germany). Patch electrodes were(Langosch et al., 1994; Rees et al., 1994; Shiang et al.,
pulled from borosilicate glass capillaries (Biomedical Instruments,
1995; Milani et al., 1996; Lewis et al., 1998). Because Germany) on a programmable pipette-puller (Zeitz Instruments,
of their molecularly defined defects and their graded Augsburg, Germany) and had resistances ranging from 2 to 6 M
phenotypes, GlyR mouse mutants so far constitute the when filled with intracellular solution. Series resistance compensa-
tion was more than 50%. Hypoglossal motoneurons were voltageonly experimental models of the human hyperekplexia
clamped at a holding potential of 70 mV. Currents were filtered atsyndrome. The data presented here suggests that some
3 kHz with a four-pole Bessel filter and digitized at 10 kHz using ayet unclassified forms of hyperekplexia may involve mu-
PowerLab/8s recording unit and Chart 4.2 software (ADInstrumentstations in the human GlyT2 gene, especially in cases
Pty. Ltd., Mountain View, CA) and stored on hard disk for offline
where no GlyR deficits could be identified (Vergouwe et analysis. Spontaneous and miniature IPSCs were analyzed using
al., 1997). Thus, the GlyT2 gene is a candidate disease the Mini Analysis program (Jaejin Software, Leonia, NJ) as described
gene, and our GlyT2/ mice might constitute a new in the accompanying paper (Gomeza et al., 2003). The aCSF con-
tained (in mM): 118 NaCl, 3 KCl, 1.5 CaCl2, 1 MgCl2, 1 NaH2PO4, 25valuable model for human diseases.
NaHCO3, and 30 D-glucose (pH 7.4). The osmolarity of the aCSF
was 310 mosm/l. Experiments were performed at room temperature.Experimental Procedures
During IPSC recordings, 20 M 6-cyano-7-nitroquinoxaline-2,3-
dione (CNQX), 100 M DL-2-amino-5-phosphonopentanoate (AP5,Generation of GlyT2/ Mice
Alexis), and 20 M bicuculline were added to the external solution.The mouse gene encoding GlyT2 was isolated from a mouse geno-
mic library prepared from 129SvJ mouse DNA (Genome Systems, For mIPSC recordings, tetrodotoxin (TTX, 0.5 M) was added to the
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aCSF to block synaptic transmission. To increase the apparently spastic mice expressing low levels of glycine receptor beta-subunit:
an animal model of startle disease. Eur. J. Neurosci. 12, 27–32.low frequency of mIPSCs, sucrose (100 mM) was added to increase
the osmolarity of the solution. The electrode solution contained (in Bengel, D., Murphy, D.L., Andrews, A.M., Wichems, C.H., Feltner,
mM): 110 CsCl, 30 TEA-Cl, 1 CaCl2, 2 MgCl2, 4 Na2ATP, 10 HEPES, D., Heils, A., Mossner, R., Westphal, H., and Lesch, K.P. (1998).
10 EGTA (pH adjusted to 7.2 with KOH). The equilibrium potential Altered brain serotonin homeostasis and locomotor insensitivity to
for chloride was at about 0 mV. Therefore, with the holding potential 3, 4-methylenedioxymethamphetamine (“Ecstasy”) in serotonin
of 70 mV, we observed IPSCs as inward currents. Drugs were transporter-deficient mice. Mol. Pharmacol. 53, 649–655.
obtained from Sigma (St. Louis, MO), Alomone Labs (Israel), and
Bennett, M.K., Calakos, N., and Scheller, R.H. (1992). Syntaxin: aTocris Cookson Ltd. (Bristol, UK).
synaptic protein implicated in docking of synaptic vesicles at pre-
synaptic active zones. Science 257, 255–259.
Electrophysiological Recording of mIPSCs in Cell Culture
Breitinger, H.G., and Becker, C.M. (1998). The inhibitory glycineThe whole-cell configuration of the patch-clamp technique was used
receptor: prospects for a therapeutic orphan? Curr. Pharm. Des.to record mIPSCs at room temperature (20C–25C) in the presence
4, 315–334.of tetrodotoxin (0.5 M), bicuculline (30 M), and 6-cyano-7-nitro-
Buckwalter, M.S., Cook, S.A., Davisson, M.T., White, W.F., andquinoxaline-2,3-dione (CNQX, 10 M) as described previously
Camper, S.A. (1994). A frameshift mutation in the mouse alpha 1(Laube, 2002). The holding potential was 70 mV. Electrodes were
glycine receptor gene (Glra1) results in progressive neurologicalpulled from borosilicate glass capillaries (Hilgenberg, Malsfeld, Ger-
symptoms and juvenile death. Hum. Mol. Genet. 3, 2025–2030.many) with a Zeitz DMZ Universal Puller (Zeitz Instruments, Augs-
burg, Germany) to yield tip resistances of 2–6 M. Pipettes were Cho, K.O., Hunt, C.A., and Kennedy, M.B. (1992). The rat brain post-
filled with a solution containing (in mM): 120 CsCl, 20 tetraethylam- synaptic density fraction contains a homolog of the Drosophila
monium chloride, 1 CaCl2, 2 MgCl2, 11 EGTA, and 10 HEPES (pH discs-large tumor suppressor protein. Neuron 9, 929–942.
7.2). The bathing Ringer solution consisted of (in mM): 137 NaCl,
Dumoulin, A., Rostaing, P., Bedet, C., Levi, S., Isambert, M.F., Henry,5.4 KCl, 1.8 CaCl2, 1 MgCl2, 20 glucose, and 5 HEPES (pH 7.4). J.P., Triller, A., and Gasnier, B. (1999). Presence of the vesicularCurrent recordings were obtained with an EPC-9 amplifier (HEKA
inhibitory amino acid transporter in GABAergic and glycinergic syn-Elektronik, Lambrecht, Germany) controlled by HEKA software.
aptic terminal boutons. J. Cell Sci. 112, 811–823.mIPSCs were acquired for 10 min, sampled at 10 kHz, stored on
Feng, G., Tintrup, H., Kirsch, J., Nichol, M.C., Kuhse, J., Betz, H.,disk, and evaluated offline as described (Laube, 2002). Drugs were
and Sanes, J.R. (1998). Dual requirement for gephyrin in glycineapplied using a microcapillary application system (DAD-12; Adams
receptor clustering and molybdoenzyme activity. Science 282,and List, Westbury, NY) and purchased from Sigma (Deisenhofen,
1321–1324.Germany) with the exception of CNQX, which was from Tocris Cook-
son (Bristol, UK). Differences in mean amplitudes and frequencies Friauf, E., Aragon, C., Lohrke, S., Westenfelder, B., and Zafra, F.
of mIPSCs were examined by Student’s two-tailed t test and consid- (1999). Developmental expression of the glycine transporter GLYT2
ered to be statistically significant at p  0.05. in the auditory system of rats suggests involvement in synapse
maturation. J. Comp. Neurol. 412, 17–37.
Miscellaneous Methods Gainetdinov, R.R., Jones, S.R., Fumagalli, F., Wightman, R.M., and
RNA isolation, RT-PCR analysis, the preparation of brain mem- Caron, M.G. (1998). Re-evaluation of the role of the dopamine trans-
branes, [3H]glycine transport assays, Western blotting, and the his- porter in dopamine system homeostasis. Brain Res. Brain Res. Rev.
tological analysis of tissue sections were performed as described 26, 148–153.
in the accompanying paper (Gomeza et al., 2003). Antibodies spe-
Gomeza, J., Hulsmann, S., Ohno, K., Eulenburg, V., Szoke, K., Rich-
cific for PSD-95 (1:1000) and syntaxin (1:1000) were obtained from
ter, D., and Betz, H. (2003). Inactivation of the glycine transporter 1
Chemicon (Hofheim, Germany).
gene discloses vital role of glial glycine uptake in glycinergic inhibi-
tion. Neuron 40, this issue, 785–796.
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